Maryia Zhdanava
Vice President at Analysis Group, Inc.
Key Impact
She is a health economics and outcomes research author whose real-world studies on esketamine and treatment-resistant depression help characterize access, utilization, costs, and outcomes in psychiatric care.
Background & Research
Maryia Zhdanava is a researcher at Analysis Group in Montréal, Canada, and appears as a corresponding author on multiple real-world evidence studies in depression and esketamine. Publicly indexed papers list her as a vice president at Analysis Group, and several publications use the corresponding email format Masha.Zhdanava@analysisgroup.com. Her work focuses on claims-based outcomes, healthcare utilization, costs, and treatment patterns in psychiatric and other therapeutic areas.
Collaboration Network
3 collaborators· click a node to visit their profile
Full network →